Our recent work utilizing liver-specific GPS2 KO mice uncovered a hitherto unknown role of GPS2 as an epigenetic modulator in hepatocytes that represses PPARα-dependent lipid catabolism and thereby promotes the development of NAFLD (44). This evidence concerns the gene GPS2 and metabolic dysfunction-associated steatotic liver disease.